Research and Achievements

Fiscal Year 2019

Achievements for Fiscal Year 2019

  1. Karigane D, Kikuchi T, Sakurai M, Kato J, Yamane Y, Hashida R, Abe R, Hatano M, Hasegawa N, Wakayama M, Shibuya K, Okamoto S, Mori T. Invasive hepatic mucormycosis: A case report and review of the literature. J Infect Chemotherapy. 2019 Jan. 25(1):50-53.
  2. Asakura T, Nakagawa T, Suzuki S, Namkoong H, Morimoto K, Ishii M, Kurashima A, Betsuyaku T, Ogawa K, Hasegawa N; Nontuberculous Mycobacteriosis Japan Research Consortium (NTM-JRC). Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease. J Infect Chemother. 2019 Mar.25(3):218-221.
  3. Izumi K, Morimoto K, Hasegawa N, Uchimura K, Kawatsu L, Ato M, Mitarai S. Epidemiology of adults and children treated for nontuberculous mycobacterial pulmonary disease in Japan. Ann Am Thorac Soc 2019 Mar. 16(3):431-437.
  4. Kusumoto T, Asakura T, Suzuki S, Okamori S, Namkoong H, Fujiwara H, Yagi K, Kamata H, Ishii M, Betsuyaku T, Hasegawa N. Development of lung cancer in patients with nontuberculous mycobacterial lung disease. Respir Invest. 2019 Mar. 57(2):157-164.
  5. Asakura T, Suzuki S, Funkano H, Okamori S, Kusumoto T, Uwamino Y, Ogawa T, So M, Uno S, Namkoong H, Yoshida M, Kamata H, Ishii M, Nishimura T, Hoshino Y, Hasegawa N. Sitafloxacin-containing regimen for thw treatment of refractory Mycobacterium avium complex lung disease. Open Forum Infect Dis 2019 Mar 7. 6(4).ofz108.
  6. Fukano H, Yoshida M, Shouji M, Hatta S, Maruyama D, Izutsu K, Shiotsuka M, Ogura Y, Hayashi T, Hasegawa N, Iwata S, Hoshino Y. Draft genome sequence of Mycolicibacterium sp. Strain NCC-Tsukiji, isolated from blood culture of a patient with malignant lymphoma. Microbiol Resour Announc. 2019 Apr 4. 8(14):e01575-18.
  7. Kimizuka Y, Hoshino Y, Nishimura T, Asami T, Sakakibara Y, Morimoto K, Maeda S, Nakata N, Abe T, Uno S, Namkoong H, Fujiwara H, Funatsu Y, Yagi K, Fujie T, Ishii M, Inase N, Iwata S, Kurashima A, Betsuyaku T, Hasegawa N; Non-Tuberculous Mycobacteriosis-Japan Research Consortium (NTM-JRC). Retrospective evaluation of natural course in mild cases of Mycobacterium avium complex pulmonary disease. PLoS One. 2019 Apr 25. 14(4):e0216034.
  8. Kobayashi K, Asakura T, Kawada I, Hasegawa H, Chubachi S, Ohara K, Kuramoto J, Sugiura H, Fujishima S, Iwata S, Umeyama T, Katano H, Uwamino Y, Miyazaki Y, Kamei K, Hasegawa N, Betsuyaku T. Disseminated histoplasmosis from a calcified lung nodule after long-term corticosteroid therapy in an elderly Japanese patient. Medicine. 2019 Apr. 98(17):e15264.
  9. Namkoong H, Ishii M, Fujii H, Asami T, Yagi K, Suzuki S, Azekawa S, Tasaka S, Hasegawa N, Betsuyaku T. Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice. Biochem Biophys Res Commun. 2019 May 28. 513(2):405-411.
  10. Yamazaki R, Kato J, Koda Y, Sakurai M, Tozawa K, Okayama M, Nakayama H, Watanuki S, Kikuchi T, Hasegawa N, Okamoto S, Mori T. Impact of immunoglobulin G2 subclass level on late-onset bacterial infection after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2019 Jun. 21(3):e13086.
  11. Kwak N, Dalcolmo MP, Daley CL, Eather G, Gayoso R, Hasegawa N, Jhun BW, Koh WJ, Namkoong H, Park J, Thomson R, van Ingen J, Zweijpfenning SMH, Yim JJ. Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis. Eur Respir J. 2019 Jul 11. 54(1). 1801991.
  12. Hashimoto M, Iketani O, Ichinose N, Enoki Y, Taniguchi K, Uwamino Y, Hasegawa N, Mastumoto M. Evaluation for optimal dosing of vancomycin in patients with different physical types 2019 Sep. 25(9):735-737.
  13. Morimoto K, Izumi K, Ato M, Hasegawa N, Mitarai S. Actual practice of standard treatment for pulmonary nontuberculous mycobacteriosis in Japan. Respir Med 2019 Oct-Nov.158:67-69.
  14. Kobayashi H, Shinjoh M, Sudo K, Kato S, Morozumi M, Koinuma G, Takahashi T, Takano Y, Tamura Y, Hasegawa N. Nosocomial infection by human Bocavirus and Human Rhinovirus among paediatric patients with respiratory risks. J Hosp Infect. 2019 Nov. 103(3):341-348.
  15. Uwamino Y, Kubota H, Sasaki T, Kosaka A, Furuhashi M, Uno S, Kudoh J, Murata M, Hasegawa N. Recovery of FRI-5 carbapenemase at a Japanese hospital where FRI-4 carbapenamase was discovered. J Antimicrob Chemother 2019 Nov 1.74(11):3390-3392.
  16. Kwak N, Dalcolmo M P, Daley CL, Eather G, Hasegawa N, Koh WJ, Thomson R, van Ingen J, Yim JJ. Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics? Eur Respir J. 2019 Nov 28. 54(5):1901806.
  17. Yamabe Y, Ito Y, Suzuki K, Kikuchi T, Ogawa K, Fujiuchi S, Hasegawa N, Kurashima A, Higuchi T, Uchiya KI, Watanabe A, Niimi A. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan. J Infect Chemother 2019 Dec. 25(12):995-1000.
  18. Takemura Y, Hibi T, Shinoda M, Obara H, Minagawa T, Kitago M, Yagi H, Abe Y, Matsubara K, Oshima G, Hori S, Hoshino K, Yamada Y, Itano O, Takano Y, Kuroda T, Hasegawa N, Kitagawa Y. Methicilin-resistant Staphylococus aureus cariiers are vulnerable to bloodstream infection after living donor liver transplantation. Clin Transplant 2019 Dec. 33(12):e13753.
  19. Uwamino Y, Nishimura T, Sato Y, Tamizu E, Asakura T, Uno S, Fujiwara H, Mori M,Wakui M, Murata M, Hasegawa N. Low serum estradiol levels are related to Mycobacterium avium complex lung disease: a cross-sectional study. BMC Infect Dis 2019 Dec 16. 19(1):1055.
  20. Imai K, Misawa K, Osa M, Tarumoto N, Sakai J, Mikita K, Sayama Y, Fujikura Y, Kawana A, Murakami T, Maesaki S, Miura S, Maeda T. Chagas disease: a report of 17 suspected cases in Japan, 2012-2017. Trop Med Health. 2019 Jun 13;47:38.
  21. Sakata H, Watanabe A, Iwata S, Sato Y, Suzuki K, Miyashita N, Hori S, Yamaguchi Y, Odajima M, Katakuse Y, Hasegawa T, Maki N, Wada K. Surveillance on susceptibility of strains isolated from pediatric infections. J Infect Chemother. 2019 Mar;25(3):163-169.
  22. Ubukata K, Morozumi M, Sakuma M, Adachi Y, Mokuno E, Tajima T, Iwata S; AOM Surveillance Study Group. Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan. J Infect Chemother. 2019 Sep;25(9):720-726.
  23. Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2019 Sep;25(9):657-668.
  24. Yoshida N, Kobayashi S, Suzuki J, Azuma Y, Kobayashi-Ogata N, Kartikasari DP, Yanagawa Y, Iwata S. Growth-promoting effects of the hydrogen-sulfide compounds produced by Desulfovibrio desulfuricans subsp. desulfuricans co-cultured with Escherichia coli (DH5α) on the growth of Entamoeba and Endolimax species isolates from swine. Biosci Trends. 2019 Nov 13;13(5):402-410.

Return to the List of
Research and Achievements